Company Profile

DBV Technologies S.A. (NASDAQ: DBVT)
11:03 AM EDT, 04/23/24
Last: $0.69 Change: +0.03 %Change: +4.39% Volume: 57,740
Detailed Quote
Open: $ 0.69   Volume: 57,740
High: $ 0.71   Yield(%) 0.00
Low: $ 0.69   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 127.00M
EPS ($) -0.38   Shares Out: 192.42M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -15.79
% Price Change (last 13 weeks): -24.02
% Price Change (last 26 weeks): -38.22
% Price Change (last 52 weeks): -58.43
% Price Change (year to date): -30.73
Management Effectiveness
Return on Equity (%): -43.47
Return on Assets (%): -33.87
Return on Invested Capital (%): -67.67
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $0.79
200-day Moving Average: $1.09
Avg. Daily Vol. (last 50 days): 57,791
Avg. Daily Vol. (last 200 days): 192,708
52-wk high: $2.37
52-wk low: $0.65
Bid: $0.67
Ask: $0.70
Company Information
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
DBV Technologies S.A.
177-181, avenue Pierre Brossolette
Montrouge IF 92120

Phone: 33.1.55.42.78.78
Fax: 33.1.43.26.10.83
http://www.dbv-technologies.com
Per Share Data
Earnings (1year) ($): -0.38
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.73
Cash Flow ($): -0.40
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 1.31
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 4.26
Current Ratio (x): 4.26
LT Debt/Equity (x): 3.23
Total Debt/Equity (x): 10.26



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.